
Life Sciences
We develop and produce active ingredients for the pharmaceutical industry, with applications in human health.
Our portfolio comprises different families of active ingredients, developed and produced based on our scientific, technological and manufacturing expertise.
Our Active Ingredients
Heparins
We produce and commercialize different types of bovine- and porcine-derived heparin for pharmaceutical and diagnostic applications.
Bovine-Derived Heparins
Bovine heparin is one of Syntex’s key differentiators. It is produced at a dedicated facility exclusively for bovine-derived products, with no cross-contamination with porcine-derived material.
Our portfolio includes:
-
Injectable-grade sodium heparin.
-
Injectable-grade calcium heparin.
-
Low molecular weight heparin, currently under development.
We also hold Halal certifications, enabling us to meet the requirements of different markets.

Porcine-Derived Heparins
Our portfolio includes:
-
Injectable-grade sodium heparin.
-
Injectable-grade calcium heparin.
-
Lithium heparin for diagnostic use.
-
Ammonium heparin for diagnostic use.
-
Injectable-grade low molecular weight heparin.
Sodium and calcium heparins are primarily used for the prevention of blood clotting and thrombus formation during cardiovascular procedures, as well as for the prevention or treatment of thromboembolic disorders.
Lithium and ammonium heparins are used as in vitro anticoagulant agents for blood sample collection and for the preparation of heparinized syringes and tubes.
Low molecular weight heparin is an antithrombotic agent used for the prophylaxis of perioperative thrombosis and the treatment of thromboembolic disorders. Syntex has developed its own patented methods for its production.


